↓ Skip to main content

Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.

Overview of attention for article published in JAMA Internal Medicine, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
22 news outlets
blogs
4 blogs
policy
1 policy source
twitter
601 X users
facebook
5 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
133 Mendeley
Title
Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.
Published in
JAMA Internal Medicine, December 2018
DOI 10.1001/jamainternmed.2018.4710
Pubmed ID
Authors

Bruno Kovic, Xuejing Jin, Sean Alexander Kennedy, Mathieu Hylands, Michal Pedziwiatr, Akira Kuriyama, Huda Gomaa, Yung Lee, Morihiro Katsura, Masafumi Tada, Brian Y Hong, Sung Min Cho, Patrick Jiho Hong, Ashley M Yu, Yasmin Sivji, Augustin Toma, Li Xie, Ludwig Tsoi, Marcin Waligora, Manya Prasad, Neera Bhatnagar, Lehana Thabane, Michael Brundage, Gordon Guyatt, Feng Xie

X Demographics

X Demographics

The data shown below were collected from the profiles of 601 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 133 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 13%
Student > Master 14 11%
Other 12 9%
Student > Bachelor 10 8%
Student > Ph. D. Student 9 7%
Other 16 12%
Unknown 55 41%
Readers by discipline Count As %
Medicine and Dentistry 39 29%
Nursing and Health Professions 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Agricultural and Biological Sciences 3 2%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 11 8%
Unknown 63 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 549. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2023.
All research outputs
#46,826
of 26,377,159 outputs
Outputs from JAMA Internal Medicine
#405
of 11,853 outputs
Outputs of similar age
#845
of 450,889 outputs
Outputs of similar age from JAMA Internal Medicine
#11
of 125 outputs
Altmetric has tracked 26,377,159 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,853 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,889 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.